Clinical Study No. RVT-101-3002, A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Alzheimer’s Disease.
DEMENTIA TRIALS AUSTRALIA
Clinical Study No. RVT-101-3002, A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Alzheimer’s Disease.